Prestigious award recognizes Dr. High’s contribution to improving children’s health through her gene therapy research, which began during her time at CHOP.

CHOP researchers have developed new software called CancerVar, which helps researchers assess the clinical impacts of over 13 million somatic cancer mutations.

CHOP researchers found neighborhood characteristics were associated with higher rates of SARS-CoV-2 in pregnancy during the prevaccination era of the COVID-19 pandemic.

While the benefits of exercise may outweigh the risks, genetic status should be considered when recommending it as therapy.

New study using license data from Ohio supports reevaluating comprehensive licensing policies in all states as a strategy to reduce new driver crashes.

CHOP and Penn researchers have found the combined effects of structural racism and the pandemic, known as a “syndemic,” were associated with negative postpartum mental health.

CHOP researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism.

CHOP and Penn researchers, along with others, have created a new tool that benchmarks brain development over the human lifespan, based on MRI data from more than 100,000 individuals.

Study suggests larger trend of moving away from routine opioid prescriptions after surgery.

CHOP researchers have found that multidrug resistant tumors have reduced connections between mitochondria and endoplasmic reticulum, causing signaling dysfunction.